ACE2 and chronic obstructive pulmonary disease: Our results are consistent with the observations recently reported by Song et al. It is suspected that patients with asthma and COPD are likely to have a different risk of severe COVID-19, which may be related to different angiotensin-converting enzyme II (ACE2) expression [23].